Givaudan | GIVN - Assets


Givaudan reported CHF11.86B in Assets for its fiscal semester ending in December of 2025.





Assets Change Date
Air Liquide EUR 51.91B 2.58B Dec/2025
Akzo Nobel EUR 15.49B 1.53B Mar/2026
Anheuser-Busch USD 218.81B 7.7B Dec/2025
Arkema EUR 14.22B 24.3M Mar/2026
Associated British Foods GBP 19.29B 608M Dec/2025
BASF EUR 76.17B 267M Dec/2025
Bayer EUR 107.94B 3.4B Mar/2026
Beiersdorf EUR 12.76B 166M Dec/2025
British American Tobacco GBP 109.29B 936M Dec/2025
Covestro EUR 13.47B 245M Dec/2025
Croda International GBP 3.51B 70.1M Dec/2024
Danone EUR 45.07B 1.32B Dec/2025
Diageo GBP 50.27B 950M Dec/2025
Fresenius EUR 41.4B 1.07B Dec/2025
Fresenius Medical Care EUR 31.47B 465.26M Mar/2026
Givaudan CHF 11.86B 587M Dec/2025
Heineken EUR 53.75B 2.12B Dec/2025
Henkel EUR 32.53B 258M Dec/2025
International Flavors Fragrances USD 25.14B 393M Mar/2026
Johnson Matthey GBP 5.97B 142M Jun/2026
Kerry EUR 12.51B 809.5M Dec/2024
Lonza CHF 18.97B 164M Dec/2025
L'Oréal EUR 61.82B 7.22B Dec/2025
Merck EUR 53.07B 1.54B Mar/2026
Nestle CHF 127.15B 2.97B Dec/2025
Pernod Ricard EUR 37.68B 596M Dec/2025
Reckitt Benckiser GBP 25.3B 1.11B Dec/2024
SGS CHF 6.75B 148M Dec/2024
Sika AG CHF 15.15B 245M Dec/2025
Solvay EUR 6.2B 45M Mar/2026
Tate & Lyle GBP 3.67B 67M Jun/2026
Umicore EUR 9.46B 865.5M Dec/2025
Victrex GBP 505.3M 61.6M Jun/2026